Interestingly, our results presented that double-targeted knockdown of miR-21 and CXCR4 powerfully suppressed PI3K/AKT and Raf/MEK/ERK activation, which might have significant therapeutic values and offer some insights for further investigation of the molecular mechanism in glioma pathology. The gene discussed is CXCR4; the disease is glioma.